Roflumilast Cream 0.3% in Patients With Chronic Plaque Psoriasis: Individual Patient Response From the Pooled DERMIS-1 and DERMIS-2 Phase 3 Trials. J of Skin [Internet]. 2023 Nov. 13 [cited 2025 Apr. 18];7(6):s252. Available from: https://skin.dermsquared.com/skin/article/view/2402